Essential Thrombocythemia and Pregnancy

References

• Murphy S., Iland H., Rosenthal D., Laszlo J. Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group. Sem. Hematol. 1986; 23: 177–182
   PubMed Web of Science ®Google Scholar
• Pearson T. C. Primary thrombocythaemia: diagnosis and management. Br. J. Haematol. 1991; 78: 145–148
   PubMed Web of Science ®Google Scholar
• Hehlmann R., Jahn M., Baumann B., Hillmar I., Köpcke W. Essential thrombocythemia: Clinical characteristics and course of 61 cases. Cancer 1988; 61: 2487–2496
   PubMed Web of Science ®Google Scholar
• Cortelazzo S., Viero P., Finazzi G., D'Emilio A., Roheghiero F., Barbui T. Incidence and Risk Factors for Thrombotic Complications in a Historical Cohort of 100 Patients with Essential Thrombocythemia. J. Clin. Oncol. 1990; 8: 556–562
   PubMed Web of Science ®Google Scholar
• Fenaux P., Simon M., Gaulier M. T., Lai J. L., Goudemand J., Bauters F. Clinical course of essential thrombocythemia in 147 cases. Cancer 1990; 66: 549–556
   PubMed Web of Science ®Google Scholar
• Mitus A. J., Barbui T., Laurence N., Rosenthal D. S., Vierom P., Cortelazzo S., Schafer A. J. Hemostatic complications in young patients with essential thrombocythemia. Am. J. of Med. 1990; 88: 371–375
   PubMed Web of Science ®Google Scholar
• Randi M. L., Fabris F., Girolami A. Thrombocytosis in young people: evaluation of 57 cases diagnosed before the age of 40. Blut. 1990; 60: 233–237
   PubMedGoogle Scholar
• Beressi A. H., Tefferi A., Silverstein M. N., Petitt R. M., Hoagland H. C. Outcome analysis of 36 pregnancies in essential thrombocythemia. Blood 1993; 82((Suppl. 1))383a
   Google Scholar
• Beard J., Hillmen P., Anderson C. C., Lewis S. M., Pearson T. C. Primary thrombocythaemia in pregnancy. Br. J. Haematol. 1991; 77: 371–374
   PubMed Web of Science ®Google Scholar
• Bellucci S., Janvier M., Tobelem G., Flandin G., Charpak Y., Berger R., Boiron M. Essential thrombocythemia. Clinical evolutionary and biological data. Cancer 1986; 58: 2440–2447
   PubMed Web of Science ®Google Scholar
• Chow E. Y., Haley L. P., Vickars L. M. Essential thrombocythemia in pregnancy: platelet count and pregnacy outcome. Am. J. Hematol. 1992; 41: 249–251
   PubMed Web of Science ®Google Scholar
• Millard F. E., Hunter C. S., Anderson M., Edelman M. J., Kosty M. P., Luiken G. A., Marino G. G. Clinical manifestations of essential thrombocythemia in young adults. Am. J. of Hematol. 1990; 33: 27–31
   PubMed Web of Science ®Google Scholar
• Falconer J., Pineo G., Blahey W., Bowen T., Docksteader B., Jadusingh I. Essential thrombocythemia associated with recurrent abortions and fetal growth retardation. Am. J. Hematol. 1987; 25: 345–347
   PubMed Web of Science ®Google Scholar
• Hoagland H. C., Silverstein M. Primary thrombocythemia in the young patient. Mayo Clin. Proc. 1978; 53: 578–550
   PubMed Web of Science ®Google Scholar
• Linares M., Pastor E., Jarque I., Sanz G., Sanz M. Essential thrombocythemia and pregnancy. Am. J. Hematol. 1988; 28: 66
   PubMed Web of Science ®Google Scholar
• Mercer B., Drouin J., Jolly E., d'Anjou G. Primary thrombocythemia in pregnancy: a report of two cases. Am. J. Obstetr. Gynecol. 1988; 159: 127–128
   PubMed Web of Science ®Google Scholar
• Okayasu N., Murata M., Ueda A., Su K. M., Sada T., Ito T., Hasegawa Y., Matsumoto S., Ito Y. Primary thrombocythemia and myocardial infarction in a 26-year-old woman with normal coronary arteriogram. Jpn. Heart. J. 1981; 22(3)439–440
   PubMedGoogle Scholar
• Kaibara M., Kobayashi T., Matsumoto S. Idiopathic thrombocythemia and pregnancy: report of a case. Obstetrics and Gynecology 1985; 65((Suppl.))18s–19s
   PubMedGoogle Scholar
• Jones E., Mosesson M., Thomason J., Jackson T. Essential thrombocythaemia in pregnancy. Obstet. Gynecol. 1988; 71: 501–503
   PubMed Web of Science ®Google Scholar
• Sanada M. Three successful pregnancies in a woman with essential thrombocythaemia. Eur. J. Haematol. 1989; 42: 215–216
   PubMed Web of Science ®Google Scholar
• Ferrari A., Mazzucconi M. G., Giona F., Paesono R., Pachi A. letter. Haematologica 1989; 74: 115
   PubMed Web of Science ®Google Scholar
• Gadisseur A., Stevens M., De Bock R., Moldenhauer R., Peetermans M. Delivery of normal twins in a patient with essential thrombocythemia treated with aspirin, dipyridamol and thrombocytapheresis. Br. J. Haematol. 1991; 79: 665
   Google Scholar
• Pineo G. F., Blahey W. B. Essential thrombocythaemia and complications of pregnancy (letter to the editor). Am. J. Hematol. 1991; 36: 221
   PubMed Web of Science ®Google Scholar
• Petit J. J., Callis M., Fernandez deSilva A. Normal pregnancy in a patient with essential thrombocythemia treated with interferon-alpha 2b. Am. J. Hematol. 1992; 40: 80
   PubMed Web of Science ®Google Scholar
• Pardini S., Dore F., Murineddu M., Bontigli S., Longinotti M., Grigliotti B., Spano B. Alpha 2b-interferon therapy and pregnancy—report of a case of essential thrombocythemia. Am. J. Hematol. 1993; 43: 78–79
   PubMed Web of Science ®Google Scholar
• Vianelli N., Gugliotta L., Tura S., Bovicelli L., Gabrielli A. Interferon-alpha 2a treatment in pregnant woman with essential thrombocythemia. Blood 1994; 83: 874–875
   PubMed Web of Science ®Google Scholar
• Williams J. M., Schlesinger P. E., Gray A. G. Successful tratment of essential thrombocythemia and recurrent abortion with alpha interferon. Br. J. Haematol. 1994; 88: 647–648
   PubMed Web of Science ®Google Scholar
• Thornley S., Manoharan A. Successful treatment of essential thrombocythemia with alpha interferon during pregnancy. Eur. J. Haematol. 1994; 52: 63–64
   PubMed Web of Science ®Google Scholar
• Tomiyama J., Komeno T., Nanki T., Kaneko H., Kudo H., Teratani T., Moriya K. Essential thrombocythemia in pregnancy. Rinsho Ketsueki 1993; 34: 1579–1583
   PubMedGoogle Scholar
• Avigdor S., du Rouchet E., Body G. Essential thrombocythemia and pregnancy. A review of the literature. J. Gynecol. Obstet. Biol. Reprod. 1993; 22: 635–639
   PubMedGoogle Scholar
• Solal-Celigny P., Fernandez H., Tertian G. Pregnancy in patients with essential thrombocythemia. Three cases. Presse Med. 1992; 21: 2085–2088
   PubMed Web of Science ®Google Scholar
• Cairns J. W., Mahon A., Waters D. A. W., Chanarin I. Platelet levels in pregnancy. J. Clin. Path. 1977; 30: 392
   PubMed Web of Science ®Google Scholar
• Sejeny S. A., Eastham R. D., Baker S. R. Platelet counts during normal pregnancy. J. Clin. Path. 1975; 28: 812–813
   PubMed Web of Science ®Google Scholar
• Turhan A. G., Humphries R. K., Cashman J. D., Cuthbert D. A., Eaves C. J., Eaves A. C. Transient suppression of clonal hemopoiesis associated with pregnancy in a patient with a myeloproliferative disorder. J. of Clin. Invest. 1988; 81: 1999–2003
   PubMed Web of Science ®Google Scholar
• Patrono C. Aspirin as an antiplatelet drug. N. Engl. J. Med. 1994; 330: 1287–1294
   PubMed Web of Science ®Google Scholar
• Beaufils M., Uzan S., Donsimoni R., Colau J. Prevention of pre-eclampsia by early anti-platelet therapy. Lancet 1985; I: 840–842
   Web of Science ®Google Scholar
• Griesshammer M., Nussbaumer B., Brommer A. E., Seifried E., Heimpel H. Incidence of acquired von Willebrand's disease in patients with essential thrombocythemia. Onkologie 1994; 17((Suppl.2))48
   Google Scholar
• van Genderen P. J. J., Michiels J. J. Primary thrombocythemia: diagnosis, clinical manifestations and management. Ann. Hematol. 1993; 67: 57–62
   PubMed Web of Science ®Google Scholar
• Lewis R. B., Schulman J. D. Influence of acetlysali-cylic acid, an inhibitor of prostaglandin synthesis on the human gestation and labour. Lancet 1973; II: 1159
   Google Scholar
• Collins E., Turner G. Maternal effects of regular salicylate ingestion in pregnancy. Lancet 1975; II: 335
   Google Scholar
• Turner G., Collins E. Fetal effects of regular salicylate ingestion in pregnancy. Lancet 1975; II: 338
   Google Scholar
• Nicholson H. O. Cytotxic drugs in pregnancy. J. Obstet. Gynaec. Brit. Cwlth. 1968; 75: 307–312
   PubMedGoogle Scholar
• Patel M., Dukes I. A. F., Hull J. C. Use of hydroxyurea in chronic myeloid leukaemia during pregnancy: a case report. Am. J. Obstet. and Gynecol. 1991; 165: 565–566
   PubMed Web of Science ®Google Scholar
• Tertian G., Tchernia G., Papiernik E., Elefant E. Hydroxyurea and pregnancy. Am. J. Obstetr. Gynecol. 1992; 166: 1869
   Google Scholar
• Delmer A., Rio B., Bauduer F., Ajchenbaum F., Marie J.-P., Zittoun R. Pregnancy during myelo-suppressive treatment for chronic myelogenous leukaemia. Br. J. Haematol. 1992; 82: 783–784
   PubMed Web of Science ®Google Scholar
• Jackson N., Shukri A., Ali K. Hydroxyurea treatment for chronic myeloid leukaemia during pregnancy. Br. J. Haematol. 1993; 85: 203–204
   PubMed Web of Science ®Google Scholar
• Baer M. R. Normal full-term pregnancy in a patient with chronic myeloid leukaemia treated with interferon-α. Am. J. Hematol. 1991; 37: 66
   PubMed Web of Science ®Google Scholar
• Baer M. R., Ozer H., Foon K. A. Interferon-α therapy during pregnancy in chronic myelogenous leukaemia and hairy cell leukaemia. Br. J. Haematol. 1992; 81: 167–169
   PubMed Web of Science ®Google Scholar
• Caligiuri M. A., Mayer R. J. Pregnancy and leukemia. Sem. in Oncol. 1989; 16: 388–396
   PubMed Web of Science ®Google Scholar
• Doll D. C., Ringenberg Q. S., Yarbo J. W. Antineoplastic agents and pregnancy. Sem. in Oncol. 1989; 16: 337–346
   PubMed Web of Science ®Google Scholar
• Beard M. E. J., Conder J. L., Clark V. A. Ovarian failure following cytotoxic therapy. N. Z. Med. J. 1984; 97: 759–762
   PubMedGoogle Scholar
• Bucci L. R., Meistrich M. L. Effects of busulfan on murine spermatogenesis: cytotoxicity, sterility, sperm abnormalities, and dominant lethal mutations. Mutat. Res. 1987; 176: 259–268
   PubMed Web of Science ®Google Scholar
• Kaplan M. E., Mack K., Goldberg J. D., Donovan P. B., Berk P. D., Wasserman L. R. Polycythemia vera: an update. II. Longterm management of polycythemia vera with hydroxyurea: a progress report. Semin. Hematol. 1986; 23: 167–171
   PubMed Web of Science ®Google Scholar
• Doney K. C., Kraemer K. G., Shepard T. H. Combination chemotherapy for acute myelocytic leukemia during pregnancy: three case reports. Cancer treat. rep. 1979; 63: 369–371
   PubMedGoogle Scholar
• Chaube S., Simmel E., Lacon C. Hydroxyurea, a teratogenic chemical. Proc. Am. Assoc. Cancer Res. 1963; 4: 10
   Google Scholar
• Singh H., Taylor C. Effects of thio-tepa and hydroxyurea on sperm production in lakeview hamsters. J. Toxicol. Environ. Health 1981; 8: 307–316
   PubMed Web of Science ®Google Scholar
• Seifried E., Griesshammer M. Treatment of essential thrombocythemia: Prelimininary results of a prospective multicenter trial. Onkologie 1994; 17((Suppl.2))48
   Google Scholar
• Reichel R. P., Linkesch W., Schetitska D. Therapy with recombinant interferon alpha 2c during unexpected pregnancy in a patient with chronic myeloid leukaemia. Br. J. Haematol. 1992; 82: 472
   PubMed Web of Science ®Google Scholar
• Crump M., Wang X. H., Sermer M., Keating A. Successful pregnancy and delivery during α-interferon therapy for chronic myeloid leukaemia. Am. J. Hematol. 1992; 40: 238
   PubMed Web of Science ®Google Scholar
• Davidson H. S., Schilsky R. L., Golomb H. M. Gonadal and sexual function following treatment of hairy cell leukemia with recombinant interferon-α. Amer. Soc. Clin. Oncol. (ASCO). Ann. Mtg. 1985; 19–21
   Google Scholar
• Vassiliadis S., Athanassakis I. Type II interferon may be a potential hazardous therapeutic agent during pregnancy. Br. J. Haematol. 1992; 82: 732–733
   Web of Science ®Google Scholar
• Product information, Roferon A (Hofmann La Roche) and Intron A (Schering Corporation)
   Google Scholar
• Taft E. G., Babcock R. B., Scharfman W. B., Tartaglia A. P. Plateletpheresis in the management of thrombocytosis. Blood 1977; 50: 927–933
   PubMed Web of Science ®Google Scholar
• Goldfinger D., Thompson R., Lowe C., Kurz L., Belkin G. Long-term plateletpheresis in the management of primary thrombocytosis. Transfusion 1979; 19: 336–338
   PubMed Web of Science ®Google Scholar